‘Winner of 50 awards since its creation in 2000, LJ Com benefits from a long experience and recognition in the field of health communication. It’s a strong team, highly recognised by professionals in the sector, for whom health is above all a mission to serve others,’ explains Edouard Fillias, CEO of JIN.
‘JIN is a leader in public relations, whose digital expertise and mastery of data will strengthen our capacity for advice and action. In the future, we will be better able to support our clients as the world of healthcare undergoes major changes,’ says Laurence Jacquillat, Chairman of LJ Com.
Faced with these new challenges in healthcare, JIN and LJ Com will be in the front line to help all the players in the ecosystem to speak out in a way that is accurate, appropriate and amplified.
The group will bring together a unique range of communication skills: analysis and research to understand communities, strategy and consultancy to guide, media relations, social networks, public affairs and events to bring people together and inform, and impact measurement to assess the performance of our systems.
Our clients include major players in the pharmaceutical industry, associations and hospitals, as well as institutions such as Organon, Cerba, RELX/Elsevier, ANSES, Abbvie, Janssen, AstraZeneca, Leo Pharma, Toulouse Oncopole, Fondation A. de Rothschild hospital, French Federation of Orthodontics, French Diabetes Society, etc.
